Assessment of tumour response with 18F-fluorodeoxyglucose positron emission tomography using three-dimensional measures compared to SUVmax - A phantom study

Physics in Medicine and Biology

Volumn 53, Issue 16, 2008, Pages 4213-4230

  Boucek, J A ^a   Francis, R J ^a   Jones, C G ^a   Khan, N ^b   Turlach, B A ^b   Green, A J ^c  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ITERATIVE METHODS; MATRIX ALGEBRA; PLASTIC BOTTLES; TUMORS;

ADAPTIVE THRESHOLDS; FDG-PET; FIXED THRESHOLD; REGION-GROWING; RESPONSE MATRICES; SEMI-AUTOMATED; SEMI-QUANTITATIVE; VOLUME OF INTEREST;

ADAPTIVE ALGORITHMS;

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CLASSIFICATION ALGORITHM; DISEASE ACTIVITY; GLYCOLYSIS; PHANTOM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING; TISSUE METABOLISM; TUMOR VOLUME;

ALGORITHMS; FLUORODEOXYGLUCOSE F18; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; NEOPLASMS; PHANTOMS, IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 51849148011     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/53/16/001     Document Type: Article

References (20)

1. Akhurst T et al 2000 Tumor burden assessment with positron emission tomography with [18-F] 2-fluoro 2-deoxyglucose (FDG PET) modeled in metastatic renal cell cancer Clin. Positron Imaging 3 57-64
2. Amthauer H et al 2004 Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthemia of rectal cancer: correlation with endorectal ultrasound and histopathology Eur. J. Nucl. Med. 31 811-9
3. Boellaard R, Krak N C, Hoekstra O S and Lammertsma A A 2004 Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study J. Nucl. Med. 45 1519-27
4. Boucek J, Francis R J and Green A J 2005 Automated approach to identification and quantitation of tumour volumes in chemotherapy monitoring using FDG PET J. Nucl. Med. 46 464 (Suppl.)
5. Erdi Y E et al 1997 Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding Cancer 80 2505-9
6. Francis R J et al 2005 A prospective study of FDG PET to assess response to chemotherapy in patients with malignant pleural mesothelioma J. Nucl. Med. 46 102
7. Green A J, Baig S, Francis R J and Begent R H J 2001 Semi quantitative analysis of F18-FDG imaging using a hybrid camera for the assessment of tumor response to therapy Eur. J. Nucl. Med. 28 S132
8. 18F-FDG PET J. Nucl. Med. 43 1304-9
9. Hoekstra C J et al 2002b Monitoring response to therapy in cancer using [18F]-2fluoro-2-deoxy-d-glucose and positron emission tomography: an overview of different analytical methods Eur. J. Nucl. Med. 27 731-43
10. Keyes J W Jr 1995 SUV: Standard Uptake or Silly Useless Value? J. Nucl. Med. 36 1836-9
11. Krak N C, Boellaard R, Hoekstra O S, Twisk J W, Hoekstra C J and Lammertsma A A 2005 Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial Eur. J. Nucl. Med. 32 294-301
12. Krak N C, Hoekstra O S and Lammertsma A A 2004 Measuring response to chemotherapy in locally advanced breast cancer: methodological considerations Eur. J. Nucl. Med. 31 S103-11
13. Larson S M et al 1999 Tumour treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging: the visual response score and the change in total lesion glycolysis Clin. Positron Imaging 2 159-71
14. Nestle U, Kremp and Grosu A L 2006 Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives Radiother. Oncol. 81 209-25
15. 18F-FDG PET J. Nucl. Med. 46 1144-50
16. 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute trials J. Nucl. Med. 47 1059-66
17. Therasse P et al 2000 New guidelines to evaluate the response to treatment in solid tumours. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J. Natl Cancer Inst. 92 205-16
18. van Baardwijk A et al 2006 The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning Cancer Treat. Rev. 32 245-60
19. Weber W A et al 2001 Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging J. Clin. Oncol. 19 3058-65
20. 18F-fluorodeoxyglucose and positron emission tomography: review of the technique and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group Eur. J. Cancer 35 1773-82